Articles

rop-anthem-120715-2col.jpg

Investors betting no on Anthem mega-deal

Lots of investors are betting health insurance giants Anthem Inc. and Cigna Corp. won’t ever make it to the altar—an outlook driven by concerns antitrust regulators or other obstacles will prevent consummating the $45 billion deal.

Read More

Sale might provide salvation for Stonegate investors

After a rocky two years as a public company, perhaps the best path forward for Stonegate Mortgage Corp.—now that the board has given the company’s CEO and founder his walking papers—is to pull the rip cord and sell the business.

Read More

Merger chatter casts cloud over Dow AgroSciences

Talk of synergies and consolidation may warm the hearts of investors, who are eager for Midland, Michigan-based Dow Chemical to boost returns, but they cast uncertainty over some of central Indiana’s best scientific jobs.

Read More
focus-briefs-dowagrosciences-2col.jpg

Dow AgroSciences up for sale or spin-off, again

Dow Chemical is exploring all options for its subsidiary, Indianapolis-based Dow AgroSciences. The company employs 1,500 workers in the Indianapolis area and, as a stand-alone firm, would be the fifth-largest by revenue in Indiana.

Read More